Compare {{ providers|length }} ketamine therapy options across at-home telehealth, in-clinic IV/IM infusion, and Spravato (esketamine) REMS care. Local "near me" results are often clinic-specific; this page helps you choose the right provider category before booking.
The largest at-home sublingual-ketamine telehealth platform; clinician evaluation, lozenge shipment, and guided at-home sessions with optional integration coaching.
Out-of-pocket; HSA/FSA eligible. Screens out high-risk cardiac and psychotic histories.
Psychiatrist-led at-home ketamine program with bundled therapy sessions and integration coaching; frequently accepts some in-network insurance coverage.
Low-dose daily sublingual ketamine under medical supervision; positioned at a lower price point than session-based models.
Daily micro-dose protocol; different evidence base than the session-based Phase 2-style approach.
At-home sublingual ketamine with integration coaching; emphasizes structured 4-session programs.
Nationwide in-clinic ketamine IV and IM infusions; Stella acquired the US Field Trip clinic portfolio in 2023-2024.
One of the older dedicated ketamine-infusion clinic networks, with psychiatry-led protocols and formal outcome tracking.
Ketamine Clinics of Los Angeles
Long-running IV-ketamine clinic; published outcome research; integration-oriented protocols.
Spravato (esketamine) REMS clinics
FDA-approved esketamine nasal spray for treatment-resistant depression and depression with acute suicidal ideation. Must be administered in a REMS-certified site; patient observed for 2 hours after dosing. The only ketamine-family therapy with broad insurance coverage.
Typically covered by commercial insurance and many Medicare Part D plans after treatment-resistant depression criteria are met.
Johns Hopkins Center for Psychedelic & Consciousness Research
Academic center with active clinical trials of ketamine adjacent to their psilocybin work; not a general-public clinic but an option for trial participation.
Research access, not fee-for-service therapy.
Get notified when new ketamine providers are added
We update this directory as new clinics open and telehealth programs launch.
Cost is not the only tradeoff. Supervision level and insurance fit usually matter more than price alone when something goes wrong mid-session.
| Criteria | At-home telehealth | In-clinic IV/IM | Spravato REMS clinic |
|---|---|---|---|
| Typical cost | $200–$400/month | $350–$800/session ($2,000–$4,500 for a starting series) | $600–$900/session self-pay; often partly covered |
| Medical supervision | Remote monitor check-ins; no clinician physically present during dosing | Clinician on-site for the full infusion window | REMS-certified clinician monitors you on-site for 2 hours post-dose |
| Insurance coverage | Essentially none | Rare, and plan-dependent | Common, with prior authorization |
| Typical time to first session | Days (async intake + shipping) | 1–3 weeks (screening + scheduling) | 2–4 weeks (prior auth usually gates this) |
| Best for | Lower-risk patients who want the lowest cost and have a sober monitor at home | Patients who want the strongest evidence base and an on-site safety net | Patients whose top priority is insurance coverage and an FDA-approved treatment |
| Verdict | Cheapest, least supervised | Most clinically supervised, priciest per session | Best insurance fit, slowest to start |
Most ketamine therapy is paid out of pocket. In-clinic IV or IM infusions typically run about $350–$800 per session, and a starting series of six is often $2,000–$4,500. At-home telehealth programs usually cost about $200–$400 per month or per protocol. Spravato (esketamine) is the exception: it is FDA-approved and often partly covered by insurance, though copays and prior-authorization rules vary by plan.
Only Spravato (esketamine) has meaningful insurance coverage today. Generic IV/IM ketamine and at-home oral ketamine are used off-label, so payers rarely reimburse them and you should expect to pay directly. If insurance coverage is your priority, ask specifically about Spravato REMS clinics and confirm your diagnosis meets the plan's criteria before booking.
It depends on the drug. Off-label IV/IM or at-home ketamine is not covered by Medicaid in any state. Spravato (esketamine) is different: most state Medicaid plans have added it to their formularies with prior authorization, though a small number of states still deny it. See the ketamine therapy insurance coverage guide for a state-by-state breakdown, including Medicaid and Medicare specifics.
At-home ketamine carries more risk than supervised care because no clinician is in the room if blood pressure spikes or dissociation becomes distressing. It can still be appropriate for screened, lower-risk patients with a sober monitor present. Rule out uncontrolled hypertension, heart disease, and a history of psychosis first, and read the at-home ketamine safety checklist before you start.
Choose the provider category before chasing a "near me" result. At-home telehealth programs serve most U.S. states, so geography rarely blocks access. In-clinic IV/IM infusion centers cluster in larger metros, and Spravato REMS clinics are listed in the manufacturer's locator. Pick the category that fits your medical needs and budget, then verify the specific clinic's licensing on your state medical board.
Yes. As noted in the vetting checklist above, a legitimate ketamine provider's prescribing clinician should be a licensed MD, DO, NP, or PA in your state — a physician assistant is one of the four clinician types this site treats as an acceptable prescriber, provided their license is verifiable on your state medical board lookup and they're working within their state's scope-of-practice rules for controlled substances.
Suggest a tool, topic, or improvement that would make this site more useful.